Baxter makes $380m grab for Baxa to boost IV and oral delivery
This article was originally published in Clinica
Executive Summary
Baxter has bought privately-held pharmacy devices and software developer Baxa for $380m, an acquisition which will complement Baxter's broad IV nutrition and fluid delivery business.